US case analysis: Myriad at the Supreme Court

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

US case analysis: Myriad at the Supreme Court

Managing IP Correspondent
August 31 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

FeaturesMIP Special FocusLife Sciences 2013 (August 2013)
managing-ip.png
Managing IP Correspondent
Contact
more from across site and SHARED ros bottom lb

More from across our site

Patents
us-china-min-600.jpeg
This week on MIP: China's IP registrations fall | X hit with $105m fine
Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
Sukanya Sarkar, April 17 2025
Patents
Solar panels and wind power generation equipment
How law firms create climate for cleantech IP business
US counsel explain how they win new cleantech IP business and how they’re navigating the industry’s challenges
Rani Mehta, April 17 2025
Patents
Trio_horizontal_lresPref.jpg
Match made in heaven? NLO and Ipsilon reveal bold expansion plans
Leaders at the IP firms, which have joined forces with backing from a PE investor, share their vision of building the number one pan-European IP practice
Sukanya Sarkar, April 17 2025
Patents
CellectDelaysCOVER.jpg
Firms weigh alternatives amid fast-track design patent suspension
Firms will steer clients towards other ways of getting quicker examinations, but fear the ramifications of the USPTO’s decision
Rani Mehta, April 16 2025
Patents
Melissa Haapala.jpg
Ex-PTAB judge excited for variety at Sterne Kessler
Melissa Haapala added that returning to client advocacy and the chance to work on patent litigation were reasons for returning to private practice
Rani Mehta, April 16 2025
Patents
clark-michelle.jpg
Alston & Bird hire anticipates IP disputes focus
Michelle Clark, who has a generalist litigation background, plans to focus on IP disputes at Alston & Bird
Rani Mehta, April 15 2025
Patents
Philips 1.jpg
Breaking: Philips and Vivo settle SEP dispute
Philips and Vivo have entered into a licensing agreement, putting an end to a five-year-old telecom SEP dispute in India
Sukanya Sarkar, April 15 2025
Patents
Stefan_Mueller_2SPL.jpg
Five minutes with...Stefan Müller, 2SPL Patent Attorneys
Stefan Müller discusses managing deadlines, the importance of reflection, and why IP is more than just a 'nice to have'
April 15 2025
Trademarks
Charlotte, North Carolina, USA Skyline Aerial
Stobbs US excited to disrupt ‘greedy’ IP market
The three founders of the IP firm’s new US offering say they plan to offer a unique proposition in a market fixated by the billable hour
Max Walters, April 14 2025
Copyright
New York Times headquarter building
Why OpenAI opinion provides ‘roadmap’ for practitioners: counsel
The opinion provides useful guidance when it comes to how courts might consider contributory infringement, DMCA claims, and other issues in AI copyright cases
Rani Mehta, April 11 2025
Gift this article